Compare
Janus International Group, Inc. vs Proto Labs Inc vs Griffon Corp vs Arcosa, Inc.
| Latest fiscal year | Janus International Group, Inc. JBI | Proto Labs Inc PRLB | Griffon Corp GFF | Arcosa, Inc. ACA |
|---|---|---|---|---|
| Year ended | 2026-01-03 | 2025-12-31 | 2025-09-30 | 2025-12-31 |
| Revenue | $884.20M | $533.13M | $2.52B | $2.88B |
| Revenue growth (YoY) | -8.3% | +6.4% | -3.9% | +12.2% |
| Gross margin | 38.8% | 44.5% | 42.0% | 22.4% |
| Operating margin | 12.6% | 4.7% | 8.2% | 11.9% |
| Net margin | 6.1% | 4.0% | 2.0% | 7.2% |
| Net income | $53.80M | $21.24M | $51.11M | $208.40M |
| EPS (Diluted) | $0.38 | $0.88 | $1.09 | $4.24 |
| Operating cash flow | $139.50M | $74.50M | $357.44M | $341.10M |
| Free cash flow | $114.00M | $59.66M | $305.00M | $175.50M |
| Cash & equivalents | n/a | $110.83M | $99.05M | $214.60M |
| Total assets | $1.30B | $763.41M | $2.06B | $4.99B |
| Total liabilities | $732.50M | $89.48M | $1.99B | $2.34B |
| Shareholders' equity | $572.50M | $673.93M | $73.97M | $2.64B |
| Return on year-end equity | 9.4% | 3.2% | 69.1% | 7.9% |
| Shares outstanding | n/a | 23.63M | 46.35M | 49.00M |
Revenue, most recent five fiscal years
| Fiscal year | Janus International Group, Inc. | Proto Labs Inc | Griffon Corp | Arcosa, Inc. |
|---|---|---|---|---|
| Latest | $884.20M Ended 2026-01-03 | $533.13M Ended 2025-12-31 | $2.52B Ended 2025-09-30 | $2.88B Ended 2025-12-31 |
| 1 year earlier | $963.80M Ended 2024-12-28 | $500.89M Ended 2024-12-31 | $2.62B Ended 2024-09-30 | $2.57B Ended 2024-12-31 |
| 2 years earlier | $1.07B Ended 2023-12-30 | $503.88M Ended 2023-12-31 | $2.69B Ended 2023-09-30 | $2.31B Ended 2023-12-31 |
| 3 years earlier | $1.02B Ended 2022-12-31 | $488.40M Ended 2022-12-31 | $2.85B Ended 2022-09-30 | $2.24B Ended 2022-12-31 |
| 4 years earlier | $750.10M Ended 2022-01-01 | $488.10M Ended 2021-12-31 | $2.27B Ended 2021-09-30 | $2.04B Ended 2021-12-31 |